Cath Lab Team



Make even complex cases feel routine





The entire Cath Lab team is critical to delivering the best possible outcomes for your patients. Cardiovascular Systems, Inc. (CSI), is committed to supporting your efforts through programs specifically tailored to members of the Cath Lab team.

Our cutting-edge technology and educational courses help physicians understand the challenges that arterial calcium presents, how to intervene with Orbital Atherectomy in appropriate patients with the unified goal of helping improve patient outcomes. We collaborate with leading experts in the field to pioneer innovative solutions.


Boost your CSIQ®

Educational opportunities tailored specifically for the Cath Lab team


CSIQ is the official professional education program of CSI.

  • Comprehensive courses taught by leading orbital atherectomy experts

  • Dedicated instructors for Cath Lab team training

  • National courses



Case Studies

Real-world cases, real-world results



CSI_Arrows_White


Learn More About Our Portfolio of Products



Upcoming Conferences

Come see CSI at these industry events.

Events Calendar

« July 2020 » loading...
S M T W T F S
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1

For more information about these upcoming conferences, talk to your CSI representative.

Don’t have a CSI rep? Complete the form below to request one.

  • This field is for validation purposes and should be left unchanged.

Patient Stories

Helping you get your patients back to what matters


See the Devices in Action

How it works:

The unique mechanism of action uses a combination of centrifugal force and differential sanding to treat arterial calcium5, 50.  The Diamondback 360 MOA is designed to treat 360° of the vessel as it sands away the calcium, while allowing for continuous flow of blood and saline during orbit50.


Commitment to Clinical & Economic Rigor


Physicians and payers are increasingly seeking clinical and economic evidence to allow them to make decisions regarding optimal treatment of patients. We are focused on conducting and collecting clinical and economic evidence to demonstrate the advantages of OAS in treating complex disease states such as PAD and CAD.

We believe that the clinical data and cost-effectiveness of our OAS technology will help drive physician utilization of the OAS and sustain ongoing reimbursement coverage for our devices.11



Clinical Evidence



For more information on CSI products and technologies